hong ze jun - Net Worth and Insider Trading
hong ze jun Net Worth
The estimated net worth of hong ze jun is at least $50 Million dollars as of 2024-09-28. hong ze jun is the 2101 Beneficial owner of Shenzhen Hepalink Pharmaceutical Group Co Ltd and owns about 13,240,000 shares of Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) stock worth over $50 Million. Details can be seen in hong ze jun's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that hong ze jun has not made any transactions after 2024-06-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of hong ze jun
hong ze jun Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, hong ze jun owns 1 companies in total, including Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) .
Click here to see the complete history of hong ze jun’s form 4 insider trades.
Insider Ownership Summary of hong ze jun
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:09989 | Shenzhen Hepalink Pharmaceutical Group Co Ltd | 2024-06-06 | 2101 Beneficial owner |
hong ze jun Latest Holdings Summary
hong ze jun currently owns a total of 1 stock. hong ze jun owns 13,240,000 shares of Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) as of June 5, 2024, with a value of $50 Million.
Latest Holdings of hong ze jun
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:09989 | Shenzhen Hepalink Pharmaceutical Group Co Ltd | 2024-06-05 | 13,240,000 | 3.74 | 49,517,600 |
Holding Weightings of hong ze jun
hong ze jun Form 4 Trading Tracker
According to the SEC Form 4 filings, hong ze jun has made a total of 2 transactions in Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Shenzhen Hepalink Pharmaceutical Group Co Ltd is the acquisition of 210,000 shares on June 5, 2024, which cost hong ze jun around $742,686.
Insider Trading History of hong ze jun
- 1
hong ze jun Trading Performance
GuruFocus tracks the stock performance after each of hong ze jun's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by hong ze jun is -5.07%. GuruFocus also compares hong ze jun's trading performance to market benchmark return within the same time period. The performance of stocks bought by hong ze jun within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how hong ze jun's insider trading performs compared to the benchmark.
Performance of hong ze jun
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.87 |  | | | | |
| Relative Return to S&P 500(%) | -12.41 | | | | | |
hong ze jun Ownership Network
hong ze jun Owned Company Details
What does Shenzhen Hepalink Pharmaceutical Group Co Ltd do?
Who are the key executives at Shenzhen Hepalink Pharmaceutical Group Co Ltd?
hong ze jun is the 2101 Beneficial owner of Shenzhen Hepalink Pharmaceutical Group Co Ltd. Other key executives at Shenzhen Hepalink Pharmaceutical Group Co Ltd include 2102 Investment manager Orbimed Capital Llc , 2105 Underwriter Morgan Stanley & Co. International Plc , and 2201 Interest of corporation controlled by you Morgan Stanley International Holdings Inc. .
Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) Insider Trades Summary
Over the past 18 months, hong ze jun made 2 insider transaction in Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) with a net purchase of 670,000.
In summary, during the past 3 months, insiders sold 0 shares of Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) were sold and 670,000 shares were bought by its insiders, resulting in a net purchase of 670,000 shares.
Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shenzhen Hepalink Pharmaceutical Group Co Ltd Insider Transactions
hong ze jun Mailing Address
Above is the net worth, insider trading, and ownership report for hong ze jun. Currently GuruFocus does not have mailing address information for hong ze jun.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
